nedaplatin: Clinical Trials

35 trials of nedaplatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 unknown, 8 completed, 4 recruiting, 3 not yet recruiting. 35 Phase 2, 5 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 235Unknown 17, Completed 8, Recruiting 4, Not yet recruiting 3, Terminated 2, Active not recruiting 1
Phase 15Completed 2, Unknown 2, Recruiting 1
Phase 32Unknown 2

Follow nedaplatin: new trials by email Literature Review of nedaplatin trials Research Report on nedaplatin

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
lpromlimab and Tuvonralimab lpromlimab and Tuvonralimab Combined with Albumin-Bound Paclitaxel and Nedaplatin - Locally Advanced, Resectable
Phase 2Active not recruitingSun Yat-sen University622025-12-172026-01-28
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
Tislelizumab, Albumin-Bound Paclitaxel, cis-platinum - Esophagus Cancer
Phase 2Not yet recruitingFujian Cancer Hospital602025-08-012025-07-20
Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma
Tislelizumab, albumin-bound paclitaxel, Nedaplatin - Esophagus Cancer
Phase 2Not yet recruitingThe First Affiliated Hospital of Xiamen University262025-07-302025-06-13
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
WJB001 Capsules+Paclitaxel/Paclitaxel-albumin, WJB001 Capsules+carboplatin/Nedaplatin, WJB001 Capsules+Paclitaxel+carboplatin - Advanced Solid Tumor
Phase 1 / Phase 2RecruitingWigen Biomedicine Technology (Shanghai) Co., Ltd.862025-07-102026-09-17
Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy
Abraxane, Nedaplatin - Hepatic Artery Infusion, Liver Metastasis of Breast Cancer
Phase 2RecruitingZhejiang Cancer Hospital302025-02-012025-12-16
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
Adebellizumab, Bevacizumab, Platinum-based chemotherapy - Resectable Lung Non-Small Cell Carcinoma
Phase 2RecruitingThe First Affiliated Hospital of Guangzhou Medical University602024-09-242025-01-15
Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC
Adebrelimab, albumin paclitaxel, Nedaplatin - Esophageal Squamous Cell Carcinoma
Phase 2Not yet recruitingHarbin Medical University652024-07-302024-07-18
Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma
Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin - Esophageal Squamous Cell Carcinoma
Phase 1 / Phase 2UnknownThe First Affiliated Hospital with Nanjing Medical University362023-08-252023-08-24
Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma
Camrelizumab, Cisplatin, Carboplatin - Head and Neck Squamous Cell Carcinoma
Phase 2UnknownCancer Institute and Hospital, Chinese Academy of Medical Sciences462023-03-012023-12-20
PPIO-004 Clinical Application of Efficacy Prediction Model Based on Epigenomics Sequencing Technology in Neoadjuvant Immunotherapy for Esophageal Cancer
Tislelizumab - Esophageal Squamous Cell Carcinoma
Phase 2CompletedDaping Hospital and the Research Institute of Surgery of the Third Military Medical University1182023-01-132025-08-24
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
Nimotuzumab Combined With Neoadjuvant Chemotherapy - Head and Neck Squamous Cell Carcinoma
Phase 2UnknownXijing Hospital552022-07-012022-07-05
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
Tislelizumab, Albumin paclitaxel, Nedaplatin - Immunotherapy Esophagus Cancer
Phase 2RecruitingFuzhou General Hospital932022-05-312024-02-07
Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma
Nedaplatin, Cisplatin - Head and Neck Squamous Carcinoma
Phase 2UnknownGuiyang Medical University1642021-09-012021-09-09
Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer
Cisplatin/Nedaplatin, albumin paclitaxel - Hypopharyngeal Cancer
Phase 2UnknownChinese PLA General Hospital302021-07-012024-02-20
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
Docetaxel, nedaplatin, fluorouracil, IMRT, Nedaplatin - Nasopharyngeal Carcinoma
Phase 2CompletedAffiliated Cancer Hospital & Institute of Guangzhou Medical University322021-05-012022-05-10
Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Toripalimab, Paclitaxel-albumin, Nedaplatin - Esophageal Squamous Cell Carcinoma
Phase 2UnknownSun Yat-sen University1242021-02-202024-02-09
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin - Esophageal Carcinoma, Neoadjuvant Immunotherapy
Phase 1 / Phase 2UnknownBeijing Friendship Hospital892020-10-292023-03-21
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
Docetaxel, Nedaplatin, Endostar - Esophageal Cancer
Phase 2UnknownFirst Affiliated Hospital of Guangxi Medical University1862018-11-012018-08-28
SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer
SHR-1210, Apatinib, Irinotecan Injection - Esophageal Squamous Cell Carcinoma
Phase 2UnknownChinese Academy of Medical Sciences452018-07-312020-02-11
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
IMRT simultaneous integrated boost, Nimotuzumab, Paclitaxel - Esophageal Neoplasms
Phase 2UnknownChinese Academy of Medical Sciences1202016-06-012019-07-26

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Esophageal Neoplasms (9)  ·  Esophageal Squamous Cell Carcinoma (7)  ·  Nasopharyngeal Carcinoma (6)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Uterine Cervical Neoplasms (2)  ·  Carcinoma, Squamous Cell (1)  ·  Central Nervous System Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Lymphoma (1)  ·  Neoplasms (1)  ·  Recurrence (1)

Sponsors

Chinese Academy of Medical Sciences (4)  ·  Sun Yat-sen University (4)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (3)  ·  Jiangsu Cancer Institute & Hospital (2)  ·  Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1)  ·  Beijing Friendship Hospital (1)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Chinese PLA General Hospital (1)  ·  First Affiliated Hospital of Guangxi Medical University (1)  ·  Fujian Cancer Hospital (1)  ·  Fuzhou General Hospital (1)  ·  Guiyang Medical University (1)  ·  Hamamatsu University (1)  ·  Harbin Medical University (1)  ·  Rongjie Tao (1)

Countries

China (26)  ·  Japan (1)

Top investigators

Zefen Xiao, MD (2)  ·  Feng Jin, Bachelor (1)  ·  Guopei Zhu, M.D. (1)  ·  Hui Liu, Professor (1)  ·  Jianqun Ma, MD (1)  ·  Jianxing He (1)  ·  Jing Huang, MD (1)  ·  Jingbo Wang (1)  ·  Jinquan Liu, M.D (1)  ·  Rong Zhang (1)  ·  Rui-hua Xu (1)  ·  Satoshi Osawa, M.D. (1)  ·  Xia He, M.D. Ph.D. (1)  ·  Xia He, M.D. and PhD (1)

Results publications

PMID 10235156, PMID 11870157, PMID 14967459, PMID 19930599, PMID 21462364, PMID 21684205, PMID 22555809, PMID 22565611, PMID 22646630, PMID 24609941, PMID 25691612, PMID 30876442, PMID 32070309, PMID 33314747, PMID 36158699, PMID 40242562, PMID 41496409, PMID 41878954, PMID 42498484